Jazz Pharmaceuticals PLC at TD Cowen Healthcare Conference Transcript
Alrighty hello everyone. I think we'll go ahead and get started.
Thank you for joining us on day two of TD Cowan's 46th annual, healthcare conference. I'm Joe Thom, one of the senior biotech analysts here on the team at TD Cowan. And it is my pleasure to have with me today several members of the Jazz Pharmaceuticals, management team. We have CFO Phil Johnson. We have the head of oncology clinical development Amal, Mellon Bertrand, and we have head of investor relations, John Bluth down there at the end. So, thank you for joining us. Maybe before we dive into the individual programs, it'd be great to start with just a brief overview of the company's recent progress and maybe your outline goals for 2026. I know we had recent, year-end, year-end financials. So, if you want to kick it off and then we'll dive in.
Well, first, thank you very much for having us. A great conference. Great to be in Boston, great lineup of investors here
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
